TNF and neoplasm: Our results revealed that the TNF‐α‐ or LPS‐simulated inflammatory microenvironment increased DNA resistance to cisplatin (Figure 3, Figure S2) and reduced the sensitivity of OS cells to cisplatin, thereby reducing tumour apoptosis and promoting survival (Figures 3 and 4, Figure S3).